Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias.
PURPOSE OF REVIEW: To highlight the indications, procedural considerations, and data supporting the use of stellate ganglion blockade (SGB) for management of refractory ventricular arrhythmias. RECENT FINDINGS: In patients with refractory ventricular arrhythmias, unilateral or bilateral SGB can reduce arrhythmia burden and defibrillation events for 24-72 h, allowing time for use of other therapies like catheter ablation, surgical sympathectomy, or heart transplantation. The efficacy of SGB appears to be consistent despite the type (monomorphic vs polymorphic) or etiology (ischemic vs non-ischemic cardiomyopathy) of the ventricular arrhythmia. Ultrasound-guided SGB is safe with low risk for complications, even when performed on anticoagulation. SGB is effective and safe and could be considered for patients with refractory ventricular arrhythmias.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Tachycardia, Ventricular
- Stellate Ganglion
- Hypertension
- Humans
- Autonomic Nerve Block
- Arrhythmias, Cardiac
- 3214 Pharmacology and pharmaceutical sciences
- 3201 Cardiovascular medicine and haematology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1103 Clinical Sciences
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Tachycardia, Ventricular
- Stellate Ganglion
- Hypertension
- Humans
- Autonomic Nerve Block
- Arrhythmias, Cardiac
- 3214 Pharmacology and pharmaceutical sciences
- 3201 Cardiovascular medicine and haematology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1103 Clinical Sciences